Government Resolves Longstanding ADHD Medication Issue

President Mohamed Muizzu has amended the Drug Act to allow the use of Methylphenidate, a medication for ADHD, effective immediately. The change follows concerns raised by Mohamed Ibrahim, who wrote to the President. The Cabinet reviewed recommendations from the National Drug Control Council and decided last month to remove the drug from the prohibited list. The proposed amendment was submitted to Parliament, endorsed by a parliamentary committee, and passed unanimously in a sitting yesterday with all 51 members present voting in favor. President Muizzu formalized the amendment via a presidential decree, published in the Government Gazette.

President Mohamed Muizzu has amended the Drug Act to allow the use of Methylphenidate, a medication for ADHD, effective immediately. The change follows concerns raised by Mohamed Ibrahim, who wrote to the President. The Cabinet reviewed recommendations from the National Drug Control Council and decided last month to remove the drug from the prohibited list. The proposed amendment was submitted to Parliament, endorsed by a parliamentary committee, and passed unanimously in a sitting yesterday with all 51 members present voting in favor. President Muizzu formalized the amendment via a presidential decree, published in the Government Gazette.

President Mohamed Muizzu has amended the Drug Act to allow the use of Methylphenidate, a medication for ADHD, effective immediately. The change follows concerns raised by Mohamed Ibrahim, who wrote to the President. The Cabinet reviewed recommendations from the National Drug Control Council and decided last month to remove the drug from the prohibited list. The proposed amendment was submitted to Parliament, endorsed by a parliamentary committee, and passed unanimously in a sitting yesterday with all 51 members present voting in favor. President Muizzu formalized the amendment via a presidential decree, published in the Government Gazette.

This story involves 1 source and may affect public understanding of pharmaceuticals / health.